Compass Therapeutics Inc.
CMPX | NASDAQ
$1.29
-$0.53 (-29.12%)
Sep 22, 2026, 10:50 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | 850K | 850K | 850K | 850K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 738K | 738K | 370K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -738K | -738K | -370K | n/a | n/a | 850K | 850K | 850K | 850K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -81.09M | -75.17M | -72.84M | -71.42M | -67.85M | -61.82M | -56.63M | -55.45M | -55.13M | -53.43M | -50.37M | -47.86M | -48.53M | -44.18M | -41.66M | -41.77M | -35.02M | -81.73M | -81.88M | -76.83M | -79.94M | -29.32M |
Interest Income | 7.64M | 7M | 6.35M | 5.67M | 5.87M | 6.65M | 7.3M | 7.69M | 7.89M | 7.98M | 7.87M | 7.19M | 5.85M | 4.22M | 2.36M | 1.07M | 449K | 34K | 29K | 43K | 64K | 62K |
Pretax Income | -73.45M | -68.17M | -66.49M | -65.81M | -62.03M | -55.22M | -49.38M | -47.76M | -47.24M | -45.44M | -42.49M | -40.67M | -42.68M | -39.9M | -39.23M | -40.63M | -34.63M | -81.92M | -82.18M | -77.58M | -80.75M | -30.5M |
Net Income | -73.45M | -68.17M | -66.49M | -65.81M | -62.03M | -55.22M | -49.38M | -47.76M | -47.24M | -45.44M | -42.49M | -40.67M | -42.68M | -39.9M | -39.23M | -40.61M | -34.61M | -81.92M | -82.18M | -77.59M | -80.77M | -30.52M |
Selling & General & Admin | 21.27M | 18.51M | 16.87M | 16.09M | 16.73M | 16.8M | 15.13M | 14.56M | 14.03M | 12.42M | 12.25M | 12.24M | 11.95M | 11.97M | 11.66M | 12.13M | 12.02M | 11.06M | 10.93M | 11.05M | 13.64M | 13.56M |
Research & Development | 59.45M | 56.29M | 55.97M | 55.33M | 51.12M | 45.88M | 42.35M | 41.73M | 41.95M | 41M | 38.12M | 35.62M | 36.58M | 32.22M | 30M | 29.64M | 23.01M | 20.05M | 20.34M | 15.17M | 15.69M | 15.77M |
Other Expenses | -370K | -370K | -370K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 50.62M | 50.62M | 50.62M | 50.62M | n/a |
Operating Expenses | 80.35M | 74.43M | 72.47M | 71.42M | 67.85M | 62.67M | 57.48M | 56.3M | 55.98M | 53.43M | 50.37M | 47.86M | 48.53M | 44.18M | 41.66M | 41.77M | 35.02M | 81.73M | 81.88M | 76.83M | 79.94M | 29.32M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.29M | 1.92M | 2.34M | 2.36M | 1.11M | 561K | 248K | 370K | 509K | 643K | 774K |
Selling & Marketing Expenses | -353K | -353K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 81.09M | 75.17M | 72.84M | 71.42M | 67.85M | 62.67M | 57.48M | 56.3M | 55.98M | 53.43M | 50.37M | 47.86M | 48.53M | 44.18M | 41.66M | 41.77M | 35.02M | 81.73M | 81.88M | 76.83M | 79.94M | 29.32M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -13K | -13K | n/a | n/a | 13K | 13K | 16K |
Shares Outstanding (Basic) | 186.8M | 186.4M | 184.84M | 138.28M | 138.28M | 138.24M | 136.63M | 137.59M | 137.59M | 136.61M | 127.67M | 127.42M | 126.73M | 126.38M | 105.19M | 101.01M | 100.95M | 100.86M | 51.91M | 61.69M | 51.91M | 51.31M |
Shares Outstanding (Diluted) | 186.8M | 186.4M | 184.84M | 138.28M | 138.28M | 138.24M | 136.63M | 137.59M | 137.59M | 136.61M | 127.67M | 127.42M | 126.73M | 126.38M | 105.19M | 101.01M | 100.95M | 100.86M | 51.91M | 61.69M | 51.91M | 51.31M |
EPS (Basic) | -0.41 | -0.43 | -0.44 | -0.47 | -0.45 | -0.40 | -0.36 | -0.36 | -0.36 | -0.36 | -0.33 | -0.32 | -0.35 | -0.33 | -0.36 | -0.51 | -0.50 | -1.49 | -1.56 | -1.45 | -1.50 | -0.54 |
EPS (Diluted) | -0.41 | -0.43 | -0.44 | -0.47 | -0.45 | -0.40 | -0.36 | -0.36 | -0.36 | -0.36 | -0.33 | -0.32 | -0.35 | -0.33 | -0.36 | -0.51 | -0.50 | -1.49 | -1.56 | -1.45 | -1.50 | -0.54 |
EBITDA | -72.67M | -67.05M | -65.37M | -64.7M | -60.47M | -53.57M | -47.62M | -46.2M | -45.69M | -43.88M | -40.91M | -38.77M | -40.13M | -36.9M | -36.25M | -37.7M | -32.33M | -80.03M | -80.19M | -74.51M | -77.52M | -27.11M |
EBIT | -73.45M | -68.17M | -66.49M | -65.81M | -62.03M | -55.22M | -49.38M | -47.76M | -47.24M | -45.44M | -42.49M | -40.67M | -42.06M | -38.85M | -38.16M | -39.52M | -34.06M | -81.67M | -81.81M | -76.81M | -79.85M | -29.47M |
Depreciation & Amortization | 778K | 1.12M | 1.12M | 1.11M | 1.56M | 1.65M | 1.75M | 1.56M | 1.56M | 1.57M | 1.58M | 1.91M | 1.93M | 1.95M | 1.9M | 1.82M | 1.74M | 1.65M | 1.62M | 2.3M | 2.33M | 2.35M |
Add to Watchlist
Select watchlists to add or remove CMPX